#973 Global Rank Marché Ouvert

Cheng Cheung Ling

Santé & Biotech. pharmaceuticals.

Fortune Nette (Est.)

$4.5 B
-$165 (-0.00%) Aujourd'hui
Portefeuille : Sino Biopharmaceutical ▼ Volatile
Cheng Cheung Ling

Photo: Press Agency / 2026

Profil Financier

Cheng Cheung Ling occupe actuellement le rang #973 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $4.5 B (-$165 sur 24h).

Cheng Cheung Ling is the vice chairlady and executive director of Hong Kong-listed drug maker Sino Biopharmaceutical.

Cheng holds a MBA from Peking University's Guanghua School of Management.

Cheng is the mother of Sino's chairman Theresa Tse and wife of cofounder Tse Ping.

Cheng's son Eric rose to CEO in 2022 and is the company's largest individual shareholder.

Historique de Fortune (12 Mois)

1A 5A Max
Jan 25 Juin 25 Déc 25 Auj.

Répartition des Actifs

Actif / Société Parts Détenues Valeur Est. Tendance
Sino Biopharmaceutical (1177-HK) 5.01B parts $3.6 B Volatile

Profil Index

Âge 62 ans
Nationalité Chi
Résidence Hong Kong, Chine
Éducation
Source pharmaceuticals
Philanthropie Score: 0/5
Indice de Puissance
Low High
Voir le classement Santé

"Cheng Cheung Ling is the vice chairlady and executive director of Hong Kong-listed drug maker Sino Biopharmaceutical."

Tags

pharmaceuticals Healthcare Self-made Chine